semaglutide banned in mississippi Shame on you and West Virginia | Plastic Surgeon San Francisco Trump announces $50/month GLP-1 weight

Wegovy is not on the VA national formulary and requires a non-formulary drug request and prior approval

Providers may request periodic updates

The broader health impacts of GLP-1s are just beginning to be felt, showing incredible promise in improving metabolic health and even treating addiction

NICE guidelines (NG28) recommend regular blood glucose monitoring during treatment transitions to prevent hyperglycaemia and ensure metabolic stability

Ozempic (semaglutide) injectioncompelling weight loss across doses

What To Expect During the Transition During the first 24 weeks after the switch, individuals may experience temporary changes, including: Mild nausea Fluctuating appetite Altered digestion or fullness cues Slower or faster weight changes These effects generally settle as the body adapts to tirzepatides dual-hormone activity